Physician
Radiation Oncology
Dr. Rachelle Lanciano, MD
|
|
Give Review
Dr. Rachelle Lanciano practices Radiation Oncology. He has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Rachelle Lanciano is a published doctor. He published 59 publications, including: 'Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?' Rachelle Lanciano accepts Medicare.
Publications
- Effect of fractionation in stereotactic body radiation therapy using the linear quadratic model.
- Stereotactic body radiation therapy for the primary treatment of localized prostate Cancer.
- Stereotactic body radiotherapy for re-irradiation of lung Cancer recurrence with lower biological effective doses.
- SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN ...
- A "Red Shell" concept of increased radiation damage hazard to normal tissues just outside the PTV target volume.
- Smoking behavior in women with locally advanced Cervical carcinoma: a Gynecologic Oncology Group study.
- Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.
- Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced Cervical carcinoma: a Gynecologic Oncology G...
- Outcome of stage IVA cervical Cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
- Impact of hydronephrosis on outcome of stage IIIB cervical Cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gy...
- Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal Cancer.
- Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical Cancer: a gynecologic oncology g...
- Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced Cervical carcinoma? Analysis of two Gynecologic Oncology Group ...
- A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung Cancer.
- Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix Cancer: a gynecologic o...
- Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical Cancer with radiotherapy.
- Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial Cancer?
- Which prognostic factors influence the outcome of patients with surgically staged endometrial Cancer treated with adjuvant radiation?
- Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields.
- The relationship of local and distant failure from endometrial Cancer: defining a clinical paradigm.
- Intra- and perioperative complications associated with tandem and colpostat application for cervix Cancer.
- The management of early ovarian Cancer.
- Wound complications after resection and immediate postoperative brachytherapy in the management of soft-tissue Sarcomas.
- Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial Cancer.
- Intraoperative radiation therapy: cut bait or keep on fishing?
- Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence.
- The influence of surgical margins on advanced Cancer treated with intraoperative radiation therapy (IORT) and surgical resection.
- A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a Radiation Therapy Oncology Group (RTOG) study.
- Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander.
- The influence of treatment time on outcome for squamous cell Cancer of the uterine cervix treated with radiation: a patterns-of-care study.
- Limb-preserving treatment for soft tissue Sarcomas of the extremities. The significance of surgical margins.
- Lymphangiography as a staging tool for cervix Cancer: limited value after hip arthroplasty.
- The justification for a surgical staging system in endometrial carcinoma.
- Groin node irradiation for vulvar Cancer: treatment planning must do more than scratch the surface.
- Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial Cancer patients: a multivariate...
- Management of retroperitoneal Sarcomas: does dose escalation impact on locoregional control?
- Improved treatment planning for the Syed-Neblett template using endoRectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: a new integrat...
- Combined modality treatment for carcinomas of the uterine cervix and vulva.
- Treatment-related myelodysplastic syndrome following abdominopelvic radiotherapy for endometrial Cancer.
- Adjuvant treatment for endometrial Cancer: who needs it?
- Polarographic needle electrode measurements of oxygen in rat Prostate carcinomas: accuracy and reproducibility.
- Management of extremity soft tissue Sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiothera...
- Postoperative radiation therapy for surgically staged endometrial Cancer: impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome.
- Recurrent ovarian Cancer. Effective radiotherapeutic palliation after chemotherapy failure.
- The efficacy of cranial irradiation in ovarian Cancer metastatic to the brain: analysis of 32 cases.
- Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.
- Radiation therapy for gynecologic Cancer.
- Update on the role of radiotherapy in ovarian Cancer.
- Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation.
- Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of c...
- Tumor and treatment factors improving outcome in stage III-B cervix Cancer.
- Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation.
- Comparison of 1 vs 2 or more intracavitary brachytherapy applications in the management of carcinoma of the cervix, with irradiation alone.
- A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical Cancer. A study of patterns of care.
- Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell Cancer of the uterine cervix. A patterns ...
- Endometrial Cancer with para-aortic adenopathy: patterns of failure and opportunities for cure.
- Radiotherapy for gynecologic malignancies.
- Intraoperative liver radiation after partial hepatectomy in a rat model.
Schools
Med Coll Of Pa
Albert Einstein Medical Center
Hospital Of The University Of Pennsylvania
Lehigh University
Procedures Preformed
- Cancer Treatment
- External Beam Radiotherapy
- Image-Guided Radiation Therapy (IGRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- View All
Conditions Treated
- Adult Development Disorders
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- View All
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerihealth HMO
- Amerihealth PPO
- Direct POS
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Commercial Insurance Company
- CoreSource
- Carelink PPO
- Group Plan PPO
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Humana
- Keystone Health Plan East HMO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System
Hospital
-
Crozer-Chester Medical Center
Drug Facts
| NPI NUMBER | 1114927365 | |
| NPPES Provider LastName | LANCIANO | |
| NPPES Provider FirstName | RACHELLE | |
| NPPES Provider ZIPCode | 190261114 | |
| NPPES Provider State | PA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114927365 |
| Last Name Of The Provider | LANCIANO |
| First Name Of The Provider | RACHELLE |
| View All |